Our people

Having already headed up successful drug development companies, Vernalis plc Chief Executive Officer Ian Garland and Chief Financial Officer David Mackney are the perfect team to help Vernalis realise its potential.  They form part of a talented, highly qualified and knowledgeable senior management team.  

Within Vernalis Therapeutics, Inc. Donna Radzik provides a wealth of knowledge and experience in developing, manufacturing and commercializing branded prescription products in the US market.

 

Contact Vernalis Therapeutics

T: 1-484-913-0700
F: 1-610-651 5976

Contact information
Maps and directions
Contact form

To report SUSPECTED ADVERSE REACTIONS, contact Vernalis Therapeutics, Inc. at 1-855-705-9546 and drugsafety@propharmagroup.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch